[Federal Register Volume 84, Number 32 (Friday, February 15, 2019)]
[Notices]
[Page 4494]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02471]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Cancer Institute, including consideration of personnel qualifications 
and performance, and the competence of individual investigators, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Board of Scientific Counselors for Basic 
Sciences National Cancer Institute.
    Date: July 8, 2019.
    Time: 9:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Porter Neuroscience 
Building, 35 Convent Drive, Building 35 Bethesda, MD 20892.
    Contact Person: Mehrdad M. Tondravi, Ph.D., Chief, Institute 
Review Office, Office of the Director, National Cancer Institute, 
National Institutes of Health, 9609 Medical Center, Room 3W302, 
Bethesda, MD 20892-9750, 240-276-5664, [email protected].

    Name of Committee: Board of Scientific Counselors for Clinical 
Sciences and Epidemiology National Cancer Institute.
    Date: July 9, 2019.
    Time: 9:00 a.m. to 3:45 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Porter Neuroscience 
Building, 35 Convent Drive, Building 35 Bethesda, MD 20892.
    Contact Person: Brian E. Wojcik, Ph.D. Senior Review 
Administrator, Institute Review Office, Office of the Director, 
National Cancer Institute, National Institutes of Health, 9609 
Medical Center, Room 3W414, Bethesda, MD 20892-9750, 240-276-5664 
[email protected].

    Name of Committee: Board of Scientific Counselors for Clinical 
Sciences and Epidemiology National Cancer Institute.
    Date: November 4, 2019.
    Time: 9:00 a.m. to 3:45 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Natcher Building, 
Conference Room D, 45 Center Drive, Bethesda, MD 20892.
    Contact Person: Brian E. Wojcik, Ph.D. Senior Review 
Administrator, Institute Review Office, Office of the Director, 
National Cancer Institute, National Institutes of Health, 9609 
Medical Center, Room 3W414, Bethesda, MD 20892-9750, 240-276-5664 
,[email protected].

    Name of Committee: Board of Scientific Counselors for Basic 
Sciences, National Cancer Institute.
    Date: November 5, 2019.
    Time: 9:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate personal qualifications and 
performance, and competence of individual investigators.
    Place: National Institutes of Health, Natcher Building, 
Conference Room D, 45 Center Drive, Bethesda, MD 20892.
    Contact Person: Mehrdad M. Tondravi, Ph.D., Chief, Institute 
Review Office, Office of the Director, National Cancer Institute, 
National Institutes of Health, 9609 Medical Center, Room 3W302, 
Bethesda, MD 20892-9750, 240-276-5664, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: February 11, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-02471 Filed 2-14-19; 8:45 am]
 BILLING CODE 4140-01-P